Last updated: February 23, 2021
Sponsor: EMS
Overall Status: Completed
Phase
3
Condition
Chronic Pain
Muscle Pain
Acute Pain
Treatment
N/AClinical Study ID
NCT03025113
EMS0116
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
IInclusion Criteria:
- Signed Consent of the patient;
- Participants presenting musculoskeletal pain, moderate or moderately severe, with VAS (visual analog scale) greater than 40 mm for a period of less than seven (7) days.
Exclusion
Exclusion Criteria:
- Patients with any clinically significant disease that in the investigator is opinioncan´t participate in the study;
- Patients with any laboratory finding or image finding that in the investigator isopinion can´t participate in the clinical trial;
- Patients with history of hypersensitivity to any of the formula compounds;
- Participation in clinical trial in the year prior to this study;
- Pregnancy or risk of pregnancy and lactating patients;
- Patients who were in use of drugs that can interfere with evaluation;
- History of with rheumatic diseases, fibromyalgia, osteoarticular diseases, dystonia,dystrophies and myopathies, acute infectious diseases, gastric duodenal ulcer orgastritis;
- Renal or hepatic impairment.
Study Design
Total Participants: 416
Study Start date:
March 08, 2018
Estimated Completion Date:
March 27, 2020
Study Description
Connect with a study center
Allegisa
Campinas, São Paulo 13.084-791
BrazilSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.